Search hospitals > Missouri > Saint Louis
Cardinal Glennon Children's Medical Center
Claim this profileSaint Louis, Missouri 63104
Global Leader in Tumors
Global Leader in Brain Tumor
Conducts research for Leukemia
Conducts research for Neuroblastoma
Conducts research for Lymphoma
221 reported clinical trials
5 medical researchers
Summary
Cardinal Glennon Children's Medical Center is a medical facility located in Saint Louis, Missouri. This center is recognized for care of Tumors, Brain Tumor, Leukemia, Neuroblastoma, Lymphoma and other specialties. Cardinal Glennon Children's Medical Center is involved with conducting 221 clinical trials across 363 conditions. There are 5 research doctors associated with this hospital, such as William Ferguson, MD, Nitin Chouthai, MD, Deepika Bhatla, MD, and Erik Masden, MD.Area of expertise
1Tumors
Global LeaderStage IV
Stage I
Stage II
2Brain Tumor
Global LeaderStage IV
Stage I
Stage II
Top PIs
William Ferguson, MDCardinal Glennon Children's Medical Center6 years of reported clinical research
Expert in Brain Tumor
Expert in Tumors
51 reported clinical trials
91 drugs studied
Nitin Chouthai, MDSt. Louis University1 year of reported clinical research
Studies Premature Birth
Studies Bleeding
3 reported clinical trials
7 drugs studied
Deepika Bhatla, MDSt. Louis University12 years of reported clinical research
Studies Autoimmune Diseases
Studies Multiple Myeloma
2 reported clinical trials
4 drugs studied
Erik Masden, MDCardinal Glennon Children's Hospital2 years of reported clinical research
Studies Congenital Heart Defects
Studies Atrioventricular Septal Defect
1 reported clinical trial
1 drug studied
Clinical Trials running at Cardinal Glennon Children's Medical Center
Rhabdomyosarcoma
Brain Tumor
Osteosarcoma
Neuroblastoma
Non-Hodgkin's Lymphoma
Astrocytoma
Germ Cell Tumors
Langerhans Cell Histiocytosis
Medulloblastoma
Rhabdoid Tumor
Combination Chemotherapy
for Rhabdomyosarcoma
This study is evaluating whether a combination of chemotherapy drugs is more effective than a single chemotherapy drug for treating rhabdomyosarcoma.
Recruiting2 awards Phase 35 criteria
Chemotherapy
for Rhabdomyosarcoma
Rhabdomyosarcoma is a type of cancer that occurs in the soft tissues in the body. This phase III trial aims to maintain excellent outcomes in patients with very low risk rhabdomyosarcoma (VLR-RMS) while decreasing the burden of therapy using treatment with 24 weeks of vincristine and dactinomycin (VA) and examines the use of centralized molecular risk stratification in the treatment of rhabdomyosarcoma. Another aim of the study it to find out how well patients with low risk rhabdomyosarcoma (LR-RMS) respond to standard chemotherapy when patients with VLR-RMS and patients who have rhabdomyosarcoma with DNA mutations get separate treatment. Finally, this study examines the effect of therapy intensification in patients who have RMS cancer with DNA mutations to see if their outcomes can be improved.
Recruiting2 awards Phase 3
Ensartinib
for Cancer
This study is evaluating whether a drug may help treat children with cancer.
Recruiting1 award Phase 217 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Cardinal Glennon Children's Medical Center?
Cardinal Glennon Children's Medical Center is a medical facility located in Saint Louis, Missouri. This center is recognized for care of Tumors, Brain Tumor, Leukemia, Neuroblastoma, Lymphoma and other specialties. Cardinal Glennon Children's Medical Center is involved with conducting 221 clinical trials across 363 conditions. There are 5 research doctors associated with this hospital, such as William Ferguson, MD, Nitin Chouthai, MD, Deepika Bhatla, MD, and Erik Masden, MD.